Impact of COVID-19 pandemic on treatment patterns in metastatic clear cell renal cell carcinoma

• Tim Eisen,
• James Larkin,
• Christian Rothermundt,
• Brian Rini,
• David McDermott,
• Manuela Schmidinger,
• Viktor Gruenwald,
• Camillo Porta,
• Bernard Escudier,
• Stefanie Aeppli,
• Eric Innocents Eboulet,
• Stefanie Fischer,
• Jan Oldenburg,
• Aurelius Omlin,
• Cora Sternberg

Affiliations

Tim Eisen

3 Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, UK

James Larkin

5 Medical Oncology, Royal Marsden Hospital NHS Trust, London, London, UK

Christian Rothermundt

1 Medical Oncology and Haematology, Kantonsspital St Gallen, Sankt Gallen, Switzerland

Brian Rini

10 Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA

David McDermott

7 Kidney Cancer Program, Dana-Farber/Harvard Cancer Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA

Manuela Schmidinger

11 Medicine I, Clinical Division of Oncology, Vienna, Austria

Viktor Gruenwald

6 Clinic for Internal Medicine (Tumor Research) and Clinic for Urology, University Hospital Essen, Essen, Germany

Camillo Porta

9 Biomedical Sciences and Human Oncology, Università degli Studi di Bari Aldo Moro, Bari, Italy

Bernard Escudier

4 Department Medical Oncology, Gustave Roussy, Villejuif, Île-de-France, France

Stefanie Aeppli

1 Medical Oncology and Haematology, Kantonsspital St Gallen, Sankt Gallen, Switzerland

Eric Innocents Eboulet

2 Coordinating Center, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland

Stefanie Fischer

1 Medical Oncology and Haematology, Kantonsspital St Gallen, Sankt Gallen, Switzerland

Jan Oldenburg

8 Division of Medicine an Laboratory Sciences, Akershus University Hospital, Lorenskog, Norway

Aurelius Omlin

1 Medical Oncology and Haematology, Kantonsspital St Gallen, Sankt Gallen, Switzerland

Cora Sternberg

12 Medical Oncology, Weill Cornell Medicine, New York, New York, USA